Trial Profile
A Thorough Corrected QT Interval Trial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs Pemafibrate (Primary) ; Moxifloxacin
- Indications Dyslipidaemias
- Focus Pharmacodynamics
- Sponsors Kowa Research Institute
- 09 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 05 Mar 2014 New trial record